The life sciences industry aims to get lifesaving medications in the hands of patients quickly, but traditional clinical trials tend to drag out that timeline. A new approach to clinical trials can reduce complexities, prevent patient-dropoff, lower costs and improve the experience for trial patients.
Our new playbook focuses on how decentralized clinical trials can help clinical trials to be more patient-centric and make them easier for patients to participate in. The playbook will explore: